Medpace
MEDP
310 hedge funds and large institutions have $3.04B invested in Medpace in 2020 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 82 increasing their positions, 125 reducing their positions, and 27 closing their positions.
130% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 27
123% more call options, than puts
Call options by funds: $3.38M | Put options by funds: $1.52M
14% more capital invested
Capital invested by funds: $2.66B → $3.04B (+$371M)
12% more funds holding
Funds holding: 277 → 310 (+33)
3.94% less ownership
Funds ownership: 80.92% → 76.98% (-3.9%)
34% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 125
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$21.6M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$19.8M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$15.4M |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$15M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$114M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40.5M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$33.6M |
| 4 |
PG
Pendal Group
Sydney,
Australia
|
-$29M |
| 5 |
Goldman Sachs
New York
|
-$24.3M |
MEDP Hedge Fund Activity: Q3 2020 in Review
310 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2020, worth a combined $3.04B — up 14% from $2.66B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new MEDP positions and 27 closed out — a net gain of 35 holders — while 82 added to existing stakes and 125 trimmed.
The largest buyer was Select Equity Group, opening a new position worth an estimated $21.6M. The largest seller was BlackRock, cutting an estimated $114M.
- 310 institutional investors held Medpace (MEDP) as of Q3 2020, up from 277 in Q2 2020.
- Funds reported $3.04B of Medpace stock for Q3 2020, up 14% quarter-over-quarter.
- 62 funds opened new Medpace positions in Q3 2020 and 27 closed out, a net change of +35 holders.
- The largest Medpace buyer in Q3 2020 was Select Equity Group, an estimated $21.6M added.
- The largest Medpace seller in Q3 2020 was BlackRock, an estimated $114M sold.
Based on aggregated 13F filings for Q3 2020.